Work

Clinical outcomes of first-line osimertinib in NSCLC patients with EGFR mutations.

Year: 2025

Type: article

Study design: Observational Study

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e20649

Authors: Yawen Wang, Guojin Zhou, Liuxian Guo, Jing Xu, Jie Chen

Institutions: The First Affiliated Hospital, Sun Yat-sen University, Guangxi Medical University, Tumor Hospital of Guangxi Medical University, Southern Medical University

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Wu Jieping Medical Foundation

Awards: G1609631254, G3359849676

OpenAlex ID: W4410809111

FWCI:

Cites:

Cited by:

Related to: 10